Asset Details
Do you wish to reserve the book?
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Do you wish to request the book?
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
2006
Overview
Tumour growth requires accompanying expansion of the host vasculature, with tumour progression often correlated with vascular density. Vascular endothelial growth factor (VEGF) is the best-characterized inducer of tumour angiogenesis. We report that VEGF dynamically regulates tumour endothelial expression of Delta-like ligand 4 (Dll4), which was previously shown to be absolutely required for normal embryonic vascular development. To define Dll4 function in tumour angiogenesis, we manipulated this pathway in murine tumour models using several approaches. Here we show that blockade resulted in markedly increased tumour vascularity, associated with enhanced angiogenic sprouting and branching. Paradoxically, this increased vascularity was non-productive-as shown by poor perfusion and increased hypoxia, and most importantly, by decreased tumour growth-even for tumours resistant to anti-VEGF therapy. Thus, VEGF-induced Dll4 acts as a negative regulator of tumour angiogenesis; its blockade results in a striking uncoupling of tumour growth from vessel density, presenting a novel therapeutic approach even for tumours resistant to anti-VEGF therapies.
Publisher
Nature Publishing Group
Subject
/ Animals
/ Humans
/ Hypoxia
/ Intracellular Signaling Peptides and Proteins
/ Membrane Proteins - antagonists & inhibitors
/ Membrane Proteins - biosynthesis
/ Membrane Proteins - genetics
/ Membrane Proteins - metabolism
/ Mice
/ Neovascularization, Pathologic - drug therapy
/ Rats
/ Receptors, Notch - metabolism
/ Rodents
/ Tumors
/ Vascular Endothelial Growth Factor A - antagonists & inhibitors
